Journey to Wealth
Daily Trading Stocks: Apex Healthcare Bhd
AHealth is likely to trade higher after closing at its highest in 52 weeks. A purchase can be made above RM3.00, with a close below the recent low of RM2.90 as a stop-loss. The price target is RM3.80, provided that the 2011's high of RM3.30 is violated. Failure to stay above RM3.00 could see it sideways with further support at RM2.75 and RM2.65.
Source: OSK
Source: OSK
Related Stocks
| Chart | Stock Name | Last | Change | Volume |
|---|
More articles on Journey to Wealth
Ekovest: No plan to launch another offer for Iskandar Waterfront City
Created by kiasutrader | Mar 29, 2018
Kenanga Research - On our Portfolio - Parliament dissolution around the corner?
Created by kiasutrader | Mar 25, 2013
Plantation Sector - Proposed accounting standard scrapped OVERWEIGHT
Created by kiasutrader | Mar 25, 2013
Pavilion Reit - Limited upside, earnings upside have been priced in HOLD
Created by kiasutrader | Mar 25, 2013
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
Introducing MY's First IPO Fund for Sophisticated Investors!
New Update. Discover investment communities that resonate with your ideas
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
.png)
MQ Trading Signals
Time
Signal
Duration
Type
2024-08-26 15:05:00
TURTLE SYSTEM 20
5 Mins
SELL
2024-08-26 15:05:00
TURTLE SYSTEM 55
5 Mins
SELL
2024-08-26 15:00:00
TURTLE SYSTEM 20
10 Mins
SELL
2024-08-26 11:30:00
ADX
30 Mins
BUY
2024-08-26 11:10:00
ADX
10 Mins
BUY
Apps
Top Articles
1
2
Koon Yew Yin's Blog
3
4
Koon Yew Yin's Blog
6
save malaysia!
7
Good Articles to Share
Boeing Embarrassed as ‘Stuck’ Astronauts to Return with SpaceX
8
Good Articles to Share
Telegram chief Pavel Durov to appear in court after French arrest
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
